Subcutaneous injections of ovine erythropoietin preparations caused parallel increases in bone marrow mitotic activity and plasma calcium concentrations. These activities appeared to be a specific property of the erythropoietin molecule and were not due to an impurity. The increased mitosis and hypercalcaemia which followed erythropoitein injection in normal rats did not occur in the aparathyroid animal. Although a functional parathyroid gland was essential for the erythropoietin-induced changes, the mode of interaction between erythropoietin and the parathyroid gland remains to be established.
INTRODUCTION
The concentration of calcium in the extracellular environment determines the rate of progression into DNA synthesis of a wide variety of cells and their subsequent entry into mitosis. This is true not only of cells isolated and maintained in vitro, but also of bone marrow and thymus cells in the whole animal (Hollingsworth, 1941; Tyler, 1941; Heilbrun, 1952 ; St Amand, Anderson & Gaulden, 1960; Whitfield & Rixon, 1962; Whitfield & Youdale, 1966; Fautrez-Firlefyn & Fautrez, 1967;  Perris, Whitfield & Rixon, 1967; Morton, 1968; Rixon, 1968; Whitfield, Rixon, Perris & Youdale, 1969) . Furthermore, it appears that natural modulations in plasma calcium concentration control the rate of cell division when there is a physiological requirement for increased cell proliferation. Thus, when the rat is growing rapidly, the level of ionized calcium in the blood parallels both the increase in mitotic activity in bone marrow and thymus and the growth rate (Perris, Whitfield & Tolg, 1968) . After haemorrhage there are also significant changes in plasma calcium levels ; the animals become hypercalcaemic and both increased cell division in the bone marrow and heightened erythropoiesis result (Perris, MacManus, Whitfield uptake of iron into erythrocyte precursors (see Goldwasser, 1966, and Jacobson, 1970 , for reviews), erythropoietin can induce hypercalcaemia in the rat. These changes are probably important in determining the enhanced erythropoiesis after natural or artificial increases in the level of erythropoietin. The presence of the parathyroid gland is essential for the manifestation of these new properties of the hormone.
MATERIALS AND METHODS
Different amounts of Step I (either 0-4 or 0-6 units/mg) or Step III (3-5 units/mg) ovine erythropoietin (obtained from Connaught Laboratories, Willowdale, Ontario, Canada) were dissolved in 0-9% NaCl solution and a single injection was given sub¬ cutaneously in the dorso-thoracic region to male albino rats, of either the SpragueDawley or Wistar strains, weighing between 180 and 220 g. No significant differences in the responses of these two strains of rat to erythropoietin were noted. At different times after this injection plasma calcium levels and mitotic activity in the bone marrow were measured. Total plasma calcium levels were measured using the tech¬ nique of Copp, Cheney & Stokoe (1963) and ionized calcium levels were determined using the Orion specific calcium ion 'flow-through' electrode system (Orion Research Inc., Cambridge, Massachusetts, U.S.A.).
Mitotic activity was normally assessed over a 6-h period by trapping cells at metaphase as they progressed through the mitotic sequence, using the metaphasearresting agent demecolcine (Colcemid, CIBA Ltd). Suspensions and smears of bone marrow cells were prepared, fixed and stained as previously described (Perris et When the effect of erythropoietin was tested in aparathyroid animals, the injection procedures outlined above were again followed. Rats were either parathyroidectomized by cautery, or surgically thyroparathyroidectomized as described by Ingle & Griffith (1942) . Sham operations were conducted in similar fashion, except that the glands in question were not removed. All operated animals were maintained on their normal diet with tap water ad libitum for the first 2 days after the operation, and then transferred to a calcium deficient diet (Kenny & Munson, 1959) with free access to distilled water for the remainder of the experiment. Only parathyroidectomized or thyroparathyroidectomized animals whose total plasma calcium concentration 4 days after the operation was less than 7-5 mg/100 ml plasma were used for subsequent experiments. Erythropoietin was administered 5 days after these various operations.
To test whether the ability of erythropoietin to increase plasma calcium concentra¬ tions was due to some specific activity of the erythropoietin molecule or to some impurity in the preparation, the molecule was specifically inactivated by mild acid hydrolysis according to the technique of Rambach, Shaw, Cooper & Alt (1958 
RESULTS

When increasing doses of
Step I erythropoietin were administered, plasma calcium concentrations showed a progressive increase 1 day later (Fig. 1) . The increment in plasma calcium concentration was maximal and of the order of 1 mg/100 ml plasma when between 10 and 20 units per 100 g body weight were given. Approximately half of this calcium increment was in the physiologically significant ionized calcium fraction (values not shown in figure) . When the more highly purified erythropoietin preparation (Step III) was given, a similar effect on plasma calcium concentration was noted at all dose levels tested. This suggested that the hypercalcaemic response was probably not due to an impurity in the erythropoietin preparation (Fig. 1 ). This conclusion was reinforced by the experiments designed to inactivate specifically the erythropoietin molecule. Dissolution of the preparation in cold water followed by immediate lyophilization had no effect on its ability to cause hypercalcaemia (com¬ pare Figs 1 and 2). A 1-h incubation at 80°C after dissolution in water followed by dialysis likewise caused only a slight reduction in calcium-increasing ability. In marked contrast the mild acid hydrolysis at 80°C completely abolished the increment in calcium concentration 24 h after the erythropoietin injection (Fig. 2) . Since other workers (Rambach et al. 1958 ) have used mild hydrolysis to remove a sialic acid moiety from the molecule and thus destroy its ability to increase the incorporation of radioactive iron into erythrocyte precursors, the present findings strongly imply that the ability to increase plasma calcium concentrations is thus a specific property of the erythropoietin molecule. Fig. 2 In parallel with the erythropoietin-induced hypercalcaemia, mitotic activity in the bone marrow was increased (Fig. 3 ). This significant (P < 0-001) increment in mitotic activity 1 day after administration of 10 units erythropoietin/100 g body weight (Fig. 3) , was ofthe same order of magnitude as that produced by parathyroid hormoneinduced hypercalcaemia Rixon, 1968) . In contrast, when erythropoietin was given to aparathyroid rats there were no significant changes in plasma calcium concentrations 1 day later (Fig. 4) . Erythropoietin also failed to stimulate bone marrow mitosis significantly in the aparathyroid rats (Table 1) . Similarly haemorrhage, which causes endogenous erythropoietin release and which has been shown to increase plasma calcium levels in normal rats ( 10-0±0-1(14) 5-0±0-2(10) 5-0±0-3(4) 2-l±0-l(6) Step I erythropoietin in 0-5 ml 0-9 % NaCl solution (10 u./lOO g body weight) was injected subcutane¬ ously into normal and TPTX rats. At no subsequent time did calcium levels in normal and TPTX rats change significantly (P > 0-1). Number of animals is given in parentheses.
or after cobaltous chloride treatment (Contopoulos, Van Dyke & Simpson, 1956; Jacobson & Goldwasser, 1958; Jepson & Lowenstein, 1968) rat plasma calcium con¬ centrations and bone marrow mitosis increase in parallel . In contrast, during transfusion-induced polycythaemia when erythropoietin levels are presumably negligible or very low (Adamson & Finch, 1968) calcium levels are decreased as is bone marrow proliferation . Similar mechanisms may exist in man. The heightened erythropoiesis which presumably accompanies and counteracts the inadequate circulation and oxygen supply to the tissues in children with cardiac defects is accompanied by increased ionized calcium concentrations in the plasma (Putman, 1972) . The present study suggests that the different circulating levels of erythropoietin in the plasma are directly responsible, via the parathyroid gland, for the calcium-induced mitotic changes in these various heightened and depressed erythropoietic circumstances.
Although to our knowledge there is no evidence to suggest that derangements in calcium homeostasis lead to clinical abnormalities in marrow cellularity, this may be because other factors will compensate for such changes. Over a long-term period erythropoietin, which has a direct effect on bone marrow cell division (Kuna, Gordon, Morse, Lane & Charipper, 1959; Matoth & Kaufmann, 1962; Reissmann & Samorapoompichit, 1970) as well as the calcium-dependent indirect effect described in the present study, will undoubtedly serve to control erythroid cellularity and circulating red cell numbers. However, when there is a sudden requirement for red cell production such as follows haemorrhage, a parathyroid-mediated hypercalcaemia plays a vital role in the rapid restoration of red cell mass .
The general ability of calcium to stimulate cell division in a wide variety of cell types is now well established (see , for detailed references). This property is shared by a number of hormones (such as growth hormone, neurohormones, para¬ thyroid hormone and prolactin) provided that calcium is present in the extracellular environment. These calcium-dependent hormones appear to sensitize the cell to calcium which initiates a chain of events culminating in mitosis . By means of a cyclic 3',5'-adenosine monophosphate increment within the cell (MacManus, Whitfield & Youdale, 1971 ; MacManus, Perris, Whitfield & Rixon, 1972) calcium and calcium-dependent hormones first induce the initiation of DNA synthesis within the cell nucleus ; this is followed by the entry of these stimulated cells into division a few hours later (MacManus & Whitfield, 1969a, (Jacobson & Goldwasser, 1958; Fried, Johnson & Heller, 1970 (Blunt, Tanaka & DeLuca, 1968; Raisz, 1970) . Whatever the mechanism, it is now quite clear that there is an important involvement of the parathyroid gland in the action of erythropoietin and in erythropoiesis in the whole animal.
A number of authors (Gallien-Lartigue & Goldwasser, 1964; Dukes & Goldwasser, 1965; Krantz & Goldwasser, 1965;  Pieber-Peretta, Rudolph, Hodgson & Peretta, 1965; Hrinda & Goldwasser, 1966; Gross & Goldwasser, 1970; Ortega & Dukes, 1970) have demonstrated that the initial or primary actions of erythropoietin on bone marrow cells are to stimulate the syntheses of RNA, haemoglobin and stromal com¬ ponents and to facilitate the incorporation of iron into red cell precursors, thus promoting the differentiation of primitive stem cells into erythroblasts. The stimula¬ tion of DNA synthesis and cell division is not necessary for the expression of these properties of erythropoietin (Erslev & Hughes, 1960;  Gallien-Lartigue & Goldwasser, 1964; Dukes & Goldwasser, 1965; Gross & Goldwasser, 1970; Ortega & Dukes, 1970) . However, erythropoietin undoubtedly does stimulate DNA synthesis and prolifera¬ tion, albeit at a later stage than the maturation effects mentioned above are manifest (Kuna et al. 1959 ; Matoth & Kaufmann, 1962; Gross & Goldwasser, 1970; Ortega & Dukes, 1970; Reissmann & Samorapoompichit, 1970; Fig. 3 ). Erythropoietin-induced and -controlled proliferation and maturation occur independently, but in parallel, to ultimately produce increased numbers of circulating erythrocytes.
Although erythropoietin can increase cell division in isolated bone marrow cells (Kuna et al. 1959 ; Matoth & Kaufmann, 1962) 
